Article

Stability of vancomycin in icodextrin peritoneal dialysis solution.

Department of Pharmaceutical Sciences, Albany College of Pharmacy, Albany, NY 12208-3492, USA.
Annals of Pharmacotherapy (impact factor: 2.13). 12/2006; 40(11):1950-4. DOI:10.1345/aph.1G321 pp.1950-4
Source: PubMed

ABSTRACT Icodextrin is a glucose polymer used as an alternative osmotic agent in peritoneal dialysis (PD) solutions. There are few data regarding the long-term stability of vancomycin in icodextrin PD solution.
To determine the chemical stability of vancomycin in icodextrin PD solution in polyvinyl chloride containers over a 7 day period at 4, 24, and 37 degrees C.
Study samples were prepared by adding 2000 mg vancomycin HCl to commercially available 2.0 L bags of icodextrin 7.5% PD solution. Nine bags were prepared and stored in the following conditions: 3 under refrigeration (5 degrees C), 3 at room temperature (24 degrees C), and 3 at body temperature (37 degrees C). Samples were withdrawn from each bag immediately after preparation and at predetermined intervals over the subsequent 7 days. Solutions were visually inspected for precipitation, cloudiness, or discoloration at each sampling interval. Total concentration of vancomycin in dialysate fluid was determined by high performance liquid chromatography.
Under refrigeration, a mean +/- SD of 99.7% +/- 0.5% of the initial vancomycin concentration remained at 168 hours (7 days). At room temperature, 97.5% +/- 3.4% remained at 168 hours. At body temperature, 94.3% +/- 3.9% remained at 24 hours. Stability was not assessed beyond these time points.
Premixed vancomycin-icodextrin PD solutions, whether stored refrigerated or at room temperature, were found to be stable for up to 7 days. However, we recommend that these solutions be kept refrigerated whenever possible. Solutions stored at body temperature were stable for up to 24 hours, permitting the practice of prewarming solutions prior to administration.

0 0
 · 
0 Bookmarks
 · 
28 Views
  • Source
    Article: Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use.
    [show abstract] [hide abstract]
    ABSTRACT: Peritoneal dialysis (PD) is an effective home-based therapy for end-stage renal failure. Intraperitoneal administration of drugs to PD patients is particularly important for the treatment of peritonitis. Clinicians need to know that the administered drug is compatible with both the PD solution and its container. A detailed literature search on drug compatibility and stability was performed and results of all published stability studies are presented for all drugs, PD solutions, and containers studied. These data will aid clinicians managing PD patients and provide a resource to demonstrate which drugs have been shown to be stable in various PD solutions and solution containers. This is important information to assist clinicians in applying effective treatments, in particular, for peritonitis.
    Peritoneal dialysis international: journal of the International Society for Peritoneal Dialysis 02/2009; 29(1):5-15. · 2.10 Impact Factor

Keywords

2000 mg vancomycin HCl
 
7 day period
 
body temperature
 
chemical stability
 
following conditions
 
glucose polymer
 
icodextrin 7.5% PD solution
 
icodextrin PD solution
 
initial vancomycin concentration
 
long-term stability
 
performance liquid chromatography
 
peritoneal dialysis
 
polyvinyl chloride containers
 
predetermined intervals
 
Premixed vancomycin-icodextrin PD solutions
 
prewarming solutions
 
room temperature
 
sampling interval
 
Study samples
 
Total concentration
 

Adwoa O Nornoo